News + Filings Holdings
|
NEA Management Company, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Coursera, Inc.
| COUR | Common | 12,867,769 | 0 | 167,538,353,000 | 19,301,654,000 | 12.79 | 8.60 |
Hist
| 06/30/2023 |
Arcellx, Inc.
| ACLX | Common | 3,745,262 | -1,000,000 | 118,425,184,000 | -27,776,338,000 | 9.04 | 7.80 |
Hist
| 06/30/2023 |
Verona Pharma plc
| VRNA | Common | 5,108,563 | -476,190 | 118,061,678,000 | 5,919,838,000 | 9.01 | 0.80 |
Hist
| 06/30/2023 |
CRISPR Therapeutics AG
| CRSP | Common | 1,587,854 | 0 | 89,142,124,000 | 17,323,488,000 | 6.80 | 2.01 |
Hist
| 06/30/2023 |
Savara Inc
| SVRA | Common | 24,137,931 | 0 | 77,120,690,000 | 30,051,725,000 | 5.89 | 21.16 |
Hist
| 06/30/2023 |
GERON CORP
| GERN | COM | 21,347,838 | 0 | 68,526,560,000 | 22,201,752,000 | 5.23 | 4.20 |
Hist
| 06/30/2023 |
Mirum Pharmaceuticals, Inc.
| MIRM | Common | 2,186,243 | -2,000,000 | 56,558,106,000 | -43,995,451,000 | 4.32 | 5.75 |
Hist
| 06/30/2023 |
Berkshire Grey, Inc.
| BGRY | Common | 38,183,023 | 0 | 53,838,062,000 | 1,145,490,000 | 4.11 | |
Hist
| 06/30/2023 |
Monte Rosa Therapeutics, Inc.
| GLUE | Common | 7,692,298 | 0 | 52,692,241,000 | -7,230,760,000 | 4.02 | 15.58 |
Hist
| 06/30/2023 |
RHYTHM PHARMACEUTICALS, INC.
| RYTM | Common | 2,909,956 | 0 | 47,985,174,000 | -3,928,441,000 | 3.66 | 5.13 |
Hist
| 06/30/2023 |
Aurinia Pharmaceuticals Inc.
| AUPH | Common | 3,969,834 | 0 | 38,427,993,000 | -5,081,388,000 | 2.93 | 2.78 |
Hist
| 06/30/2023 |
CVRx, Inc.
| CVRX | COM | 2,370,542 | 0 | 36,601,169,000 | 14,507,717,000 | 2.79 | 11.45 |
Hist
| 06/30/2023 |
Bright Health Group Inc.
| BHG | COM | 2,726,917 | 2,726,917 | 33,322,926,000 | 33,322,926,000 | 2.54 | 0.43 |
Hist
| 06/30/2023 |
X4 Pharmaceuticals, Inc
| XFOR | Common | 14,986,793 | 3,250,000 | 29,074,378,000 | 18,863,368,000 | 2.22 | |
Hist
| 06/30/2023 |
Reneo Pharmaceuticals, Inc.
| RPHM | Common | 4,785,494 | 0 | 28,253,557,000 | -363,697,000 | 2.16 | 14.22 |
Hist
| 06/30/2023 |
Trevi Therapeutics, Inc.
| TRVI | Common | 11,370,376 | 0 | 27,175,199,000 | 6,140,003,000 | 2.07 | 18.93 |
Hist
| 06/30/2023 |
Allakos Inc.
| ALLK | Common | 6,147,260 | 0 | 26,802,054,000 | -553,253,000 | 2.05 | 7.10 |
Hist
| 06/30/2023 |
Desktop Metal, Inc.
| DM | COM | 14,407,594 | 8,667 | 25,486,101,000 | -7,631,431,000 | 1.95 | |
Hist
| 06/30/2023 |
NEXTNAV INC.
| NN | Common | 8,189,156 | 0 | 24,076,119,000 | 7,452,132,000 | 1.84 | 7.60 |
Hist
| 06/30/2023 |
Black Diamond Therapeutics, Inc.
| BDTX | Common | 4,448,757 | 1,000,000 | 22,466,223,000 | 15,948,072,000 | 1.71 | 12.18 |
Hist
| 06/30/2023 |
Phathom Pharmaceuticals, Inc.
| PHAT | Common | 1,276,595 | 1,276,595 | 18,280,840,000 | 18,280,840,000 | 1.40 | 2.93 |
Hist
| 06/30/2023 |
ZeroFox Holdings, Inc.
| ZFOX | Common | 18,068,513 | 0 | 18,068,513,000 | -8,311,516,000 | 1.38 | 15.23 |
Hist
| 06/30/2023 |
Adaptimmune Therapeutics PLC
| ADAP | Common | 17,079,778 | -1 | 15,798,795,000 | -2,818,163,000 | 1.21 | 1.72 |
Hist
| 06/30/2023 |
Inozyme Pharma, Inc.
| INZY | Common | 2,437,689 | 0 | 13,577,928,000 | -390,030,000 | 1.04 | 5.54 |
Hist
| 06/30/2023 |
Celcuity Inc.
| CELC | COM | 1,250,001 | 0 | 12,725,011,000 | -87,499,000 | 0.97 | 5.69 |
Hist
| 06/30/2023 |
CHAMPIONS ONCOLOGY, INC.
| CSBR | COM NEW | 1,713,720 | 0 | 10,933,534,000 | 4,044,380,000 | 0.83 | 12.64 |
Hist
| 06/30/2023 |
Tuya Inc.
| TUYA | SPONSERED ADS | 4,934,640 | 0 | 9,326,470,000 | 0 | 0.71 | |
Hist
| 06/30/2023 |
MINERVA SURGICAL INC
| UTRS | Common | 34,437,052 | 0 | 8,822,773,000 | 2,019,733,000 | 0.67 | 19.47 |
Hist
| 06/30/2023 |
GLYCOMIMETICS INC
| GLYC | COM | 4,764,440 | 0 | 8,290,126,000 | 2,286,932,000 | 0.63 | |
Hist
| 06/30/2023 |
Nkarta, Inc.
| | Common | 3,568,781 | 0 | 7,815,630,000 | -4,853,543,000 | 0.60 | 7.29 |
Hist
| 06/30/2023 |
BuzzFeed, Inc.
| BZFD | Common | 15,333,892 | 0 | 7,743,615,000 | -9,583,683,000 | 0.59 | 10.96 |
Hist
| 06/30/2023 |
Acrivon Therapeutics, Inc.
| ACRV | Common | 481,677 | 0 | 6,242,534,000 | 1,352,549,000 | 0.48 | 2.20 |
Hist
| 06/30/2023 |
Inventiva S.A.
| IVA | Common | 1,462,586 | 0 | 5,908,847,000 | 915,578,000 | 0.45 | |
Hist
| 06/30/2023 |
LEXICON PHARMACEUTICALS, INC.
| LXRX | COM NEW | 2,382,286 | 0 | 5,455,435,000 | -333,520,000 | 0.42 | 1.26 |
Hist
| 06/30/2023 |
Gossamer Bio, Inc.
| GOSS | COM | 3,467,406 | 0 | 4,160,887,000 | -208,045,000 | 0.32 | 3.63 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|